SUMMARY Animal studies have demonstrated that synchronised coronary sinus retroperfusion with arterial blood can provide effective perfusion of ischaemic myocardium. Preliminary clinical studies have shown that the technique can also be used with safety in human beings, and in the present study its effectiveness was assessed in three patients undergoing repeated coronary artery occlusions during percutaneous transluminal coronary angioplasty. Arterial blood was removed via an 8F catheter positioned in the femoral artery and delivered by a retroperfusion pumping system to a 7F retroperfusion balloon catheter positioned in the anterior cardiac vein. Ischaemiarelated indices were monitored both before and during coronary sinus retroperfusion. These indices included high fidelity left ventricular pressure recordings and pressure derived indices (including velocities of isovolumic contraction and relaxation), as well as electrocardiographic changes and symptoms. Analysis of these variables showed that the ischaemic changes induced during coronary artery occlusion were not prevented by this type of coronary sinus retroperfusion. There was no major complication in any of the patients.
It may be that adaptation of the technique or the use of alternative end points will establish a benefit, but further modifications of the delivery system are necessary for effective clinical use.
The effective preservation of acutely ischaemic myocardium remains an elusive goal. Coronary Electrocardiograms from leads I, II, and V3 were recorded throughout the procedure and in addition an intracoronary electrocardiogram was recorded from the intraluminal balloon guide wire in one ofthe patients. The ST changes are expressed in mV and were recorded from the lead showing the maximal change in ST segment during occlusions, measured from the isoelectric line (P-Q interval) 0-08 seconds after the J point.
PROTOCOL
The protocol was approved by the ethics committee of the Thoraxcenter. The data were collected according to the guidelines of the Food and Drugs Administration of the United States and the procedures were performed with the technical assistance of representatives from the industry. Patients gave their informed consent to the study.
A pacing wire was positioned in the right atrium, and coronary angiography and left ventriculography were performed. The catheter for monitoring pressure was then positioned in the left ventricle and the retroperfusion catheter was inserted into the coronary sinus. The catheter for dilating the coronary artery was then introduced and the lesion was crossed. Two control dilatations were performed with haemodynamic monitoring before retroperfusion was started. This was started at an initial measured flow rate of 50 ml/min, increasing by 20 Tau,, changed progressively during occlusion, in keeping with induced myocardial ischaemia. Figure  2 shows the electrocardiogram, left ventricular pressure, and retroperfusion flow recordings at the end of each occlusion compared with the baseline recordings. At the end ofeach occlusion there was 0-4 mV of ST elevation; there was considerable variability in
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LV pressure tip manometer the time taken for the changes to occur and resolve (table 1) . During each of the four occlusions there were ischaemia-induced changes in the pressure derived indices, with a more pronounced change in Vmax, Tau,, and + dP/dt during the two occlusions performed with retroperfusion.
Patient 2-A 63 year old man was readmitted with chest pain at rest after a small anterior non-Q wave myocardial infarction. The pain was associated with anterior ST depression and T wave inversion. Coronary angiography showed an occluded right coronary artery and a severe proximal stenosis in the left anterior descending artery; it was therefore decided to proceed to coronary angioplasty. At angioplasty two 54 second inflations were performed before retroperfusion and one 174 second and one 54 second inflation were performed during retroperfusion. The maximal inflation pressure was 10 atmospheres. There was ST depression of 0 1 mV at the end of the first inflation, but not during the second inflation. The first inflation with retroperfusion was increased to 174 seconds, with the patient complaining of mild pain shortly after 30 seconds. There was no progression to severe chest pain during the procedure and only slow progression in ST change-0 1 mV at 70 s and 0-2 mV at 140 seconds. These changes resolved within 30 seconds of deflation. Figure 3 shows changes in + dP/dt and -dP/dt. Again the expected ischaemia-induced changes are clearly present. Although there was an "overshoot" in the + dP/dt on reperfusion, the change is not as pronounced as that seen during the shorter occlusions in patient 3 (fig 5b) . In addition, the postocclusion recordings (at 500 s) showed that all the pressure derived indices were lower than the baseline values, suggesting delayed recovery of the ischaemic myocardium. the individual inflations (fig 5a) . Similarly there was a reduction in Vmax and dP/dt and increase in Tau,.
There was a pronounced "overshoot" in positive dP/ dt on deflation, before baseline values were restored. The changes in these variables all followed the same course during all the balloon inflations; retroperfusion did not produce any significant changes. In all three patients the positioning of the catheter in the coronary sinus was a relatively simple procedure. In two patients a 0-018 inch high torque floppy guide wire was used to avoid entering the origin of the obtuse marginal vein. We found that once venous access was obtained the catheter could be positioned quickly so that when imaging is available it should be possible to set up the system and start retroperfusion within 15 minutes. 
METHOD OF ASSESSMENT
There is no consensus about the most appropriate method of assessing improvement in myocardial perfusion and function during retroperfusion. Methods which have been used to demonstrate an improvement with retroperfusion in animals include the measurement of cardiac output, electrocardiographic change, regional and global left ventricular function by echocardiography, and postmortem assessment of myocardial ischaemia by intravascular indicators.
We chose to assess the effect of synchronised retroperfusion on myocardial ischaemia during angioplasty in three ways: (a) by evaluating the severity of chest pain and the length of artery occlusion before pain; (b) by monitoring the surface and in one case the intracoronary electrocardiogram; (c) by monitoring the left ventricular pressure and the pressure derived indices.
The assessment by the assessor and patient ofchest pain in a stressed patient during an interventional procedure in which an experimental device is used is to some extent subjective. The use of an analogue scale may help to reduce this, but we believe that such an assessment will remain crude and will only be relevant when there are large changes.
ST change is widely used as an index of ischaemia although the variability of this measurement in the context of repeated coronary occlusion with intracoronary injections has not been well validated. Intracoronary electrocardiographic recordings taken from the balloon guide wire which overlies the area of ischaemic myocardium provides a more reliable measurement, ' Because the flow is limited to diastole, however, a large amount of the delivered blood is "washed out" before it reaches the capillary bed.
In our animal studies (unpublished data) we achieved effective retroperfusion in some cases with high flow rates and high coronary venous pressures by selective positioning ofthe catheter. In the present study we confirmed the position ofthe retroperfusion catheter in the great cardiac vein throughout the procedure in all three patients and demonstrated retrograde flow. Figure 2 shows a hand injection of 10 ml of contrast (not synchronised) producing clear visualisation of the anterior cardiac vein, with blushing ofthe myocardium, particularly in the septal area. The addition of contrast to the retroperfused blood during the procedure, however, suggested that synchronised delivery was much less effective at producing a myocardial blush, and it may be that higher flow rates will be necessary to achieve this. One ofthe very important considerations ofusing higher flow rates is the ability ofthe venous system to drain the increased volume of blood. In this report the comparatively slow deflation of the autoinflatable balloon is a serious limitation, and is one of the areas that need further development.
We feel that we performed appropriate monitoring to detect any improvement in the ischaemic state of the myocardium. We feel the weight of our current data precluded the use of this technique in additional patients. We have, however, been able to identify potential modifications which should substantially improve the current delivery system. It remains to be seen whether improved techniques of anterograde perfusion will make retroperfusion obsolete, but any future clinical trial must be conducted in a controlled manner and its conclusions must be based on reliable and reproducable indices of myocardial ischaemia.
